首页 | 本学科首页   官方微博 | 高级检索  
     

TC方案治疗晚期肺鳞状细胞癌与腺癌的临床疗效观察对比
引用本文:肖妹,林忠,彭培建. TC方案治疗晚期肺鳞状细胞癌与腺癌的临床疗效观察对比[J]. 中国现代医生, 2008, 46(31): 41-42
作者姓名:肖妹  林忠  彭培建
作者单位:中山大学附属第五医院肿瘤化疗科,广东,珠海,519000
摘    要:目的观察并比较紫杉醇联合卡铂方案治疗晚期肺鳞状细胞癌与晚期肺腺癌的疗效及毒副反应。方法回顾性分析81例晚期肺鳞状细胞癌与腺癌,其中鳞状细胞癌组39例,腺癌组42例。结果鳞状细胞癌组有效率为41.0%,中位TTP为5.6个月,腺癌组有效率45.2%,中位肿瘤进展时间为6.0个月,疗效无显著性差异(P〉0.05)。主要不良反应为骨髓抑制、肌肉疼痛、脱发、外周神经炎,两组无显著性差异(P〉0.05)。结论TC方案对晚期肺鳞状细胞癌与腺癌均有效,疗效与毒副反应相似。

关 键 词:肺鳞状细胞癌  肺腺癌  联合化疗  紫杉醇  卡铂

Comparison of the Effect of TC Regimen in Treatment of Advanced Squa-mous-cell Carcinoma and Adenocarcinoma of the Lung
XIAO Mei,LIN Zhong,PENG Peijian. Comparison of the Effect of TC Regimen in Treatment of Advanced Squa-mous-cell Carcinoma and Adenocarcinoma of the Lung[J]. , 2008, 46(31): 41-42
Authors:XIAO Mei  LIN Zhong  PENG Peijian
Affiliation:XIAO Mei LIN Zhong PENG Peijian Department of Medical Oncology,The Fifth Affiliated Hospital of Sun Yat-sen University,Guangdong 519000
Abstract:Objective To observe and compare the effect and toxicity of TC regimen in the treatment of patients with advanced squa-mous-cell carcinoma or adenocarcinoma of the lung.Methods Retrospective study was used to analyze the clinical data of 81 cases of ad-vanced squamous-cell carcinoma or adenocarcinoma of the lung treated with Paclitaxel plus Carboplatin.Results The overall response rate was 41.0% in advanced squamous-cell carcinoma of the lung,45.2% in advanced adenocarcinoma of the lung,The median TTP were ...
Keywords:Squamous-cell carcinoma of the lung  Adenocarcinoma of the lung  Combined chemotherapy  Paclitaxel  Carboplatin  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号